RARG and hepatocellular carcinoma: Secondly, RARγ is an oncogene for several cancers, as evidenced by overexpression in human colorectal cancer, cholangiocarcinoma, hepatocellular cancer, ovarian cancer, pancreatic ductal adenocarcinoma, and renal cell cancer [12].